Equity Profile

CTEV

Claritev Corporation

Health CareHealth Care Technology$428.2M

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Claritev Corporation operates in the health care technology sector, focusing on innovative solutions that aim to improve patient care and streamline health services. As a company with a market cap of $0 billion, its performance is closely watched by investors interested in the evolving health tech landscape.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability, and investors will be keen to see if the company can narrow its losses this quarter.

N/A

Revenue Growth

While specific revenue estimates are not available, any signs of growth or improvement in revenue would indicate a positive trend for the company.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CTEV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 5Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-51.72%

Avg Stock Reaction

+6.82%

Last Quarter Recap

In Q1-2026, Claritev reported an EPS of -$4.41, missing estimates by 15.75%. Following the announcement, the stock dropped by 8.54%.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are cautious given the company's recent history of missing earnings estimates. Investors are looking for any signs of improvement.

Bull Case

If Claritev can demonstrate a significant reduction in losses and show potential for revenue growth, it could lead to a positive market reaction.

Bear Case

Conversely, if the company continues to miss expectations, it may face further declines in stock price and investor confidence.

Expectations

Two Questions That Matter

The print will turn on these two things.

What specific measures is Claritev taking to reduce its EPS losses this quarter?

Investors will closely watch for any concrete plans or strategies that could indicate a path to profitability.

Is there any update on revenue generation or new contracts that could impact growth?

Any positive news on revenue could significantly influence investor sentiment and stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for Claritev to narrow its losses this quarter, given recent operational changes that have not been fully communicated.

Supporting Evidence

Options are pricing a 57.32% move, indicating expectations of volatility that may not align with historical performance.

The recent trend of stock reactions suggests that even small improvements could lead to significant positive movement.

Key Risk

If EPS comes in better than -$4.00, it could shift market perception dramatically.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will either confirm a turnaround strategy or highlight ongoing challenges.

Bull Confirmed If

A reduction in EPS losses to below -$3.50 would signal a positive shift in the company's financial health.

Bear Confirmed If

If EPS losses exceed -$4.50, it would reinforce concerns about the company's viability.

Pre-Earnings Positioning

Options Market

Implied Move

±57.32%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant move, suggesting that traders anticipate high volatility around the earnings report.

Options are pricing ±57.3% while CTEV has averaged ±10.3% over the last 5 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

210.8%

Calls (4K)P/C Ratio: 0.43Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Claritev beats expectations, history suggests the stock could rise by around 6.82%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity.

Miss

Should the company miss again, history indicates a potential decline of around 6.82%, raising concerns about its future.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on any new partnerships or contracts that could drive revenue.
2Updates on cost-cutting measures and their expected impact on EPS.
3Insights into the company's long-term strategy for profitability.
4Any commentary on market conditions affecting the health tech sector.
5Management's outlook on future quarters and potential revenue streams.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability, and investors will be keen to see if the company can narrow its losses this quarter.

N/A

Revenue Growth

While specific revenue estimates are not available, any signs of growth or improvement in revenue would indicate a positive trend for the company.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CTEV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 5Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-51.72%

Avg Stock Reaction

+6.82%

Last Quarter Recap

In Q1-2026, Claritev reported an EPS of -$4.41, missing estimates by 15.75%. Following the announcement, the stock dropped by 8.54%.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are cautious given the company's recent history of missing earnings estimates. Investors are looking for any signs of improvement.

Bull Case

If Claritev can demonstrate a significant reduction in losses and show potential for revenue growth, it could lead to a positive market reaction.

Bear Case

Conversely, if the company continues to miss expectations, it may face further declines in stock price and investor confidence.

Expectations

Two Questions That Matter

The print will turn on these two things.

What specific measures is Claritev taking to reduce its EPS losses this quarter?

Investors will closely watch for any concrete plans or strategies that could indicate a path to profitability.

Is there any update on revenue generation or new contracts that could impact growth?

Any positive news on revenue could significantly influence investor sentiment and stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for Claritev to narrow its losses this quarter, given recent operational changes that have not been fully communicated.

Supporting Evidence

Options are pricing a 57.32% move, indicating expectations of volatility that may not align with historical performance.

The recent trend of stock reactions suggests that even small improvements could lead to significant positive movement.

Key Risk

If EPS comes in better than -$4.00, it could shift market perception dramatically.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will either confirm a turnaround strategy or highlight ongoing challenges.

Bull Confirmed If

A reduction in EPS losses to below -$3.50 would signal a positive shift in the company's financial health.

Bear Confirmed If

If EPS losses exceed -$4.50, it would reinforce concerns about the company's viability.

Pre-Earnings Positioning

Options Market

Implied Move

±57.32%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant move, suggesting that traders anticipate high volatility around the earnings report.

Options are pricing ±57.3% while CTEV has averaged ±10.3% over the last 5 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

210.8%

Calls (4K)P/C Ratio: 0.43Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Claritev beats expectations, history suggests the stock could rise by around 6.82%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity.

Miss

Should the company miss again, history indicates a potential decline of around 6.82%, raising concerns about its future.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on any new partnerships or contracts that could drive revenue.
2Updates on cost-cutting measures and their expected impact on EPS.
3Insights into the company's long-term strategy for profitability.
4Any commentary on market conditions affecting the health tech sector.
5Management's outlook on future quarters and potential revenue streams.